Osteoporosis
Phase III Osteoporosis Drug Study Begins
Published in Women's Health Weekly, March 11th, 2000
The study is designed to demonstrate the bone-building and fracture-reducing power of the drug. It will be a multi-center trial of about 2,000 post-menopausal women who have osteoporosis. Dosing will last for 18 months, with the drug compared to placebo.
In a Phase II clinical trial of 217 osteoporotic post-menopausal women, ALX1-11 was shown to be safe and effective in producing significant increases in bone mineral density, the company said.
ALX1-11 is an injectable version of human parathyroid hormone, a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Endometrial Cancer
Endometrial Tissue Culture Mimics in vivo Changes - Alzheimer's Disease
Estrogen Therapy Does Not Appear To Slow Progression - Binge Eating Disorder
Obese Subjects Experience Less Sleep Efficiency than Normal Weight Subjects - Breastfeeding
Moderate Weight Loss OK for Overweight Moms Who Breast Feed - Endometrial Cancer
Polyps and Carcinoma Look Different with MRI - Environment
No Link Found Between PCBs and DDE and Breast Cancer Risk - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
